This interview examines the use of KIR genotyping during donor selection and its association with improved outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Katy Rezvani, MD, PhD
Advertisement
Articles by Katy Rezvani, MD, PhD
Advertisement
Latest Updated Articles
Using KIR Genotyping to Improve Transplant SuccessPublished: January 5th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Regorafenib/Nivolumab Exhibits Nonsuperior Survival in Gastric Cancer
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
4
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
5
